Selected research
Market Outlook & Growth Opportunities
Global High-Throughput Sequencing Technology Market Outlook and Growth Opportunities 2026
Market perspective
The global High-Throughput Sequencing Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the High-Throughput Sequencing Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the High-Throughput Sequencing Technology market include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global High-Throughput Sequencing Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of High-Throughput Sequencing Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents High-Throughput Sequencing Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global High-Throughput Sequencing Technology market.
High-Throughput Sequencing Technology Segment by Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
High-Throughput Sequencing Technology Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
High-Throughput Sequencing Technology Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
High-Throughput Sequencing Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global High-Throughput Sequencing Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the High-Throughput Sequencing Technology key companies, revenue, market share, and recent developments.
3. To split the High-Throughput Sequencing Technology breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions High-Throughput Sequencing Technology market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify High-Throughput Sequencing Technology significant trends, drivers, influence factors in global and regions.
6. To analyze High-Throughput Sequencing Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Throughput Sequencing Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of High-Throughput Sequencing Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Throughput Sequencing Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global High-Throughput Sequencing Technology industry.
Chapter 3: Detailed analysis of High-Throughput Sequencing Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of High-Throughput Sequencing Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of High-Throughput Sequencing Technology in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
Applications
- Hospitals and Clinics
- Biopharma Companies
- Academic & Research Organizations
- Others
Companies covered
- Eurofins Scientific
- Natera
- BGI
- Illumina
- Roche
- LabCorp
- Berry Genomics
- Brooks Life Sciences
- Macrogen
- Personalis
- Novogene
- Genotypic Technology
- Dna Link
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global High-Throughput Sequencing Technology Market Size, 2021 VS 2025 VS 2032
- 1.3 Global High-Throughput Sequencing Technology Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 High-Throughput Sequencing Technology Market Dynamics
- 2.1 High-Throughput Sequencing Technology Industry Trends
- 2.2 High-Throughput Sequencing Technology Industry Drivers
- 2.3 High-Throughput Sequencing Technology Industry Opportunities and Challenges
- 2.4 High-Throughput Sequencing Technology Industry Restraints
3 High-Throughput Sequencing Technology Market by Company
- 3.1 Global High-Throughput Sequencing Technology Company Revenue Ranking in 2025
- 3.2 Global High-Throughput Sequencing Technology Revenue by Company (2021-2026)
- 3.3 Global High-Throughput Sequencing Technology Company Ranking (2024-2026)
- 3.4 Global High-Throughput Sequencing Technology Company Manufacturing Base and Headquarters
- 3.5 Global High-Throughput Sequencing Technology Company Product Type and Application
- 3.6 Global High-Throughput Sequencing Technology Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global High-Throughput Sequencing Technology Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 High-Throughput Sequencing Technology Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 High-Throughput Sequencing Technology Market by Type
- 4.1 High-Throughput Sequencing Technology Type Introduction
- 4.1.1 Targeted Sequencing
- 4.1.2 Whole Exome Sequencing
- 4.1.3 Whole Genome Sequencing
- 4.2 Global High-Throughput Sequencing Technology Sales Value by Type
- 4.2.1 Global High-Throughput Sequencing Technology Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global High-Throughput Sequencing Technology Sales Value by Type (2021-2032)
- 4.2.3 Global High-Throughput Sequencing Technology Sales Value Share by Type (2021-2032)
5 High-Throughput Sequencing Technology Market by Application
- 5.1 High-Throughput Sequencing Technology Application Introduction
- 5.1.1 Hospitals and Clinics
- 5.1.2 Biopharma Companies
- 5.1.3 Academic & Research Organizations
- 5.1.4 Others
- 5.2 Global High-Throughput Sequencing Technology Sales Value by Application
- 5.2.1 Global High-Throughput Sequencing Technology Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global High-Throughput Sequencing Technology Sales Value by Application (2021-2032)
- 5.2.3 Global High-Throughput Sequencing Technology Sales Value Share by Application (2021-2032)
6 High-Throughput Sequencing Technology Regional Value Analysis
- 6.1 Global High-Throughput Sequencing Technology Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global High-Throughput Sequencing Technology Sales Value by Region (2021-2032)
- 6.2.1 Global High-Throughput Sequencing Technology Sales Value by Region: 2021-2026
- 6.2.2 Global High-Throughput Sequencing Technology Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America High-Throughput Sequencing Technology Sales Value (2021-2032)
- 6.3.2 North America High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe High-Throughput Sequencing Technology Sales Value (2021-2032)
- 6.4.2 Europe High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific High-Throughput Sequencing Technology Sales Value (2021-2032)
- 6.5.2 Asia-Pacific High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America High-Throughput Sequencing Technology Sales Value (2021-2032)
- 6.6.2 South America High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa High-Throughput Sequencing Technology Sales Value (2021-2032)
- 6.7.2 Middle East & Africa High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
7 High-Throughput Sequencing Technology Country-level Value Analysis
- 7.1 Global High-Throughput Sequencing Technology Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global High-Throughput Sequencing Technology Sales Value by Country (2021-2032)
- 7.2.1 Global High-Throughput Sequencing Technology Sales Value by Country (2021-2026)
- 7.2.2 Global High-Throughput Sequencing Technology Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.3.2 USA High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.7.2 France High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.14.2 China High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.17.2 India High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eurofins Scientific
- 8.1.1 Eurofins Scientific Company Information
- 8.1.2 Eurofins Scientific Business Overview
- 8.1.3 Eurofins Scientific High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.1.4 Eurofins Scientific High-Throughput Sequencing Technology Product Portfolio
- 8.1.5 Eurofins Scientific Recent Developments
- 8.2 Natera
- 8.2.1 Natera Company Information
- 8.2.2 Natera Business Overview
- 8.2.3 Natera High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.2.4 Natera High-Throughput Sequencing Technology Product Portfolio
- 8.2.5 Natera Recent Developments
- 8.3 BGI
- 8.3.1 BGI Company Information
- 8.3.2 BGI Business Overview
- 8.3.3 BGI High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.3.4 BGI High-Throughput Sequencing Technology Product Portfolio
- 8.3.5 BGI Recent Developments
- 8.4 Illumina
- 8.4.1 Illumina Company Information
- 8.4.2 Illumina Business Overview
- 8.4.3 Illumina High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.4.4 Illumina High-Throughput Sequencing Technology Product Portfolio
- 8.4.5 Illumina Recent Developments
- 8.5 Roche
- 8.5.1 Roche Company Information
- 8.5.2 Roche Business Overview
- 8.5.3 Roche High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.5.4 Roche High-Throughput Sequencing Technology Product Portfolio
- 8.5.5 Roche Recent Developments
- 8.6 LabCorp
- 8.6.1 LabCorp Company Information
- 8.6.2 LabCorp Business Overview
- 8.6.3 LabCorp High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.6.4 LabCorp High-Throughput Sequencing Technology Product Portfolio
- 8.6.5 LabCorp Recent Developments
- 8.7 Berry Genomics
- 8.7.1 Berry Genomics Company Information
- 8.7.2 Berry Genomics Business Overview
- 8.7.3 Berry Genomics High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.7.4 Berry Genomics High-Throughput Sequencing Technology Product Portfolio
- 8.7.5 Berry Genomics Recent Developments
- 8.8 Brooks Life Sciences
- 8.8.1 Brooks Life Sciences Company Information
- 8.8.2 Brooks Life Sciences Business Overview
- 8.8.3 Brooks Life Sciences High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.8.4 Brooks Life Sciences High-Throughput Sequencing Technology Product Portfolio
- 8.8.5 Brooks Life Sciences Recent Developments
- 8.9 Macrogen
- 8.9.1 Macrogen Company Information
- 8.9.2 Macrogen Business Overview
- 8.9.3 Macrogen High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.9.4 Macrogen High-Throughput Sequencing Technology Product Portfolio
- 8.9.5 Macrogen Recent Developments
- 8.10 Personalis
- 8.10.1 Personalis Company Information
- 8.10.2 Personalis Business Overview
- 8.10.3 Personalis High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.10.4 Personalis High-Throughput Sequencing Technology Product Portfolio
- 8.10.5 Personalis Recent Developments
- 8.11 Novogene
- 8.11.1 Novogene Company Information
- 8.11.2 Novogene Business Overview
- 8.11.3 Novogene High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.11.4 Novogene High-Throughput Sequencing Technology Product Portfolio
- 8.11.5 Novogene Recent Developments
- 8.12 Genotypic Technology
- 8.12.1 Genotypic Technology Company Information
- 8.12.2 Genotypic Technology Business Overview
- 8.12.3 Genotypic Technology High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.12.4 Genotypic Technology High-Throughput Sequencing Technology Product Portfolio
- 8.12.5 Genotypic Technology Recent Developments
- 8.13 Dna Link
- 8.13.1 Dna Link Company Information
- 8.13.2 Dna Link Business Overview
- 8.13.3 Dna Link High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
- 8.13.4 Dna Link High-Throughput Sequencing Technology Product Portfolio
- 8.13.5 Dna Link Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst